Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Speakers' Corner 1: AMD

10:45 - 12:15 | 20 September | Room: Speaker Corner.

Back to Previous

10:45Vitamin D and optical coherence tomography in neovascular age-related macular degeneration
C. Yasar Turkey
10:50A Nationwide Incidence of clinical exudative neovascular age-related macular degeneration under real-world medical system of South Korea and related injection use during 2010-2015
S. Kim Korea, South
10:55Use of intravitreal (IVI) bevacizumab for the treatment of choroidal neovascular membrane secondary to Sorsby fundus dystrophy
G. Tsokolas United Kingdom
11:00Evaluation of ocular blood flow with color doppler ultrasonography after intravitreal aflibercept injection
Y. Toklu Turkey
11:05Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: Twelve-month results of the TWEYEs study
F. Bandello Italy
11:10One-year results of intravitreal conbercept therapy between two different angiographic subtypes of polypoidal choroidal vasculopathy
L. Chang China
11:15Long-term incidence and growth of chorioretinal atrophy in patients with polypoidal choroidal vasculopathy
C. Lee Korea, South
11:20A clinical evaluation of efficacy of stereotactic radiotherapy in reducing the frequency of anti –VEGF injections in wet AMD
S. Joseph United Kingdom
11:25A Global Coalition of patient organisations collaborated to develop a multi stakeholder educational toolkit to improve education and outcomes of age-related macular degeneration – AMD
A. Daly Ireland
11:30Complete audit cycle on loading phase of aflibercept for treatment naive neovascular age-related macular degeneration (nAMD)
R. Crosby-Nwaobi United Kingdom
11:35One and two-year visual acuity outcomes after treatment for neovascular age-related macular degeneration at a large tertiary ophthalmic hospital
L. Raja United Kingdom
11:40Association between number of injections during long-term anti VEGF therapy and retinal electrophysiological parameters
A. Hobby United Kingdom
11:45Effectiveness of aflibercept in exudative age-related macular degeneration: Real-Life Data Study Innsbruck
T. Rauchegger Austria
11:50Variations in chorioretinal vasculatures in patients with age-related macular degeneration
C. Yun Korea, South
11:55Analysis of choroidal thickness changes in patients with exudative age‑related macular degeneration treated with aflibercept
I. Jamiołkowska Poland
12:00Novel phenotypic association of Sorsby fundus dystrophy with with polypoidal choroidal vasculopathy
T. Koutresi United Kingdom
Back to Previous

Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait